News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • European wholesale gas prices fell as traders booked profits, but U.S.-Iran tensions and shipping risks keep forward risk premia elevated.
  • Publicis shares rose after winning PepsiCo's $1.7 billion global media account, boosting its organic growth outlook and pressuring Omnicom.
  • DoorDash stock rallied on stronger revenue and margin progress, leaving valuation stretched and making execution on growth essential.
  • U.S. futures were mixed as Snowflake and Five Below jumped after earnings while Broadcom, HPE slid and Ultragenyx plunged on trial failure.
  • Treasury Secretary Bessent said the U.S. leads China in AI compute and could control about 80% of global compute by 2028.
  • Bank of Canada held rates at 2.25%, the loonie strengthened, and officials warned of rising inflation risks tied to energy and tariffs.

Latest Articles

Options Signal 12% Move for Samsara Stock Ahead of Sept. 3 Earnings

Options Signal 12% Move for Samsara Stock Ahead of Sept. 3 Earnings

Options pricing suggests Samsara Inc. Class A shares (IOT) could move roughly 12% when the company reports earnings on Sept. 3 after the market close, according to Bloomberg options data. The stock's historical reactions to earnings have often exceeded or fallen short of options-implied moves, producing an inconsistent pattern through recent announ…

Options Market Pins Asana Stock for a Rough Ride After Sept. 3 Earnings

Options Market Pins Asana Stock for a Rough Ride After Sept. 3 Earnings

Options activity suggests Asana Inc. Class A shares could move about 17% when the company reports quarterly earnings after the market close on Sept. 3. Historical comparisons show mixed alignment between implied moves and actual post-earnings swings in the stock over the past eight reports, with several instances of the share price moving much more…

MercadoLibre: Brazil Fears Are Priced In — Tactical Long Setup

MercadoLibre: Brazil Fears Are Priced In — Tactical Long Setup

MercadoLibre is trading well below its 52-week high after a correction that amplified concerns tied to Brazil. The company reported blowout revenue growth and strong fintech traction; balance sheet and cash flow strength support a tactical long. Entry at $1947.26, stop at $1800, target $2500 over a long term (180 trading days) horizon.

HEALTHY CHOICE WELLNESS CORP.’S STOCKHOLDERS APPROVE ALL PROPOSALS IN CONNECTION WITH MERGER WITH HOST DIGITAL

HEALTHY CHOICE WELLNESS CORP.’S STOCKHOLDERS APPROVE ALL PROPOSALS IN CONNECTION WITH MERGER WITH HOST DIGITAL

Healthy Choice Wellness Corp. has received stockholder approval to merge with Host Digital Infrastructure LLC, a digital infrastructure platform specializing in AI and high-performance computing data centers. The merger, expected to close by mid-September, will result in Host Digital becoming a wholly owned subsidiary of HCWC and the combined entit…

MISTRAS Group Accelerates AI and Digital Innovation Strategy

MISTRAS Group Accelerates AI and Digital Innovation Strategy

MISTRAS Group, a leader in industrial asset integrity and testing solutions, is accelerating its AI strategy to transform its expertise, data, and digital capabilities into actionable insights. The company appointed Samer F. Sarrouh as Executive Director of Artificial Intelligence to lead this initiative, aiming to improve inspection intelligence, …

ACI Worldwide: A Quiet Payments Compounder Ready for the Next Leg Up

ACI Worldwide: A Quiet Payments Compounder Ready for the Next Leg Up

ACI Worldwide is a profitable, cash-generative payments software company trading at a reasonable multiple with a clear path to higher recurring revenue and margins. Recent M&A, product wins in open banking and a large addressable market for real-time payments support a long trade. Entry at $53.00, stop at $48.00, target $65.00 over a long-term (180…

HD Hyundai Heavy Industries Union Authorizes Strike Vote After Member Ballot

HD Hyundai Heavy Industries Union Authorizes Strike Vote After Member Ballot

Members of the HD Hyundai Heavy Industries union voted in a ballot held August 25-27 to authorize strike action, with 5,379 of 8,127 members supporting the move. The result, representing 66.19% of eligible union members, clears the legal threshold for a strike. A Central Dispute Countermeasures Committee meeting is scheduled for August 28 to decide…

T1 Giga Arctic Approved for Data Center Development

T1 Giga Arctic Approved for Data Center Development

T1 Energy Inc. announced that Mo i Rana local officials have rezoned part of its Giga Arctic campus to permit the development of a 50 MW data center, expected to be operational in 2027 with potential for expansion. The company is pursuing various strategies to monetize this brownfield facility as part of its value optimization initiative, leveragin…

Philips and Imricor launch cardiac interventional MR lab solution, expanding longstanding collaboration

Philips and Imricor launch cardiac interventional MR lab solution, expanding longstanding collaboration

Royal Philips and Imricor Medical Systems have launched a new Interventional MR (iMR) lab solution combining Philips' 1.5T MRI platform and Imricor's MR-compatible cardiac intervention systems. This solution aims to enable MRI-guided cardiac interventions with improved tissue visualization, reducing reliance on X-ray fluoroscopy and radiation expos…

Moleculin CEO, Walter Klemp, Participates in the Virtual Investor “Why Now” On-Demand Conference

Moleculin CEO, Walter Klemp, Participates in the Virtual Investor “Why Now” On-Demand Conference

Moleculin Biotech's CEO Walter Klemp presented promising interim results from the pivotal Phase 2/3 MIRACLE trial of Annamycin for relapsed or refractory acute myeloid leukemia (AML). The presentation emphasized the drug's differentiated clinical profile, ongoing enrollment, expanding commercial potential, and an upcoming interim analysis of 90 pat…